Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer

International Journal of Clinical Oncology

Volumn 19, Issue 1, 2014, Pages 50-56

  Sakamoto, Jin ^a   Sonobe, Makoto ^a   Kobayashi, Masashi ^a   Ishikawa, Masashi ^a   Kikuchi, Ryutaro ^a   Nakajima, Daisuke ^a   Yamada, Tetsu ^a   Nakayama, Ei ^a   Takahashi, Tsuyoshi ^a   Sato, Toshihiko ^a   Chen, Fengshi ^a   Bando, Toru ^a   Date, Hiroshi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Non small cell lung cancer; Postoperative brain metastases; Prognostic factors

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84894546739     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0503-8     Document Type: Article

References (33)

1. Mintz A, Perry J, Spithoff K, et al. (2007) Management of single brain metastasis: a practice guideline. Curr Oncol 14:131-143
2. Kvale PA, Simoff M, Prakash UB, et al. (2003) Lung cancer. Palliative care. Chest 123:284S-311S
3. Mamon HJ, Yeap BY, Janne PA, et al. (2005) High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol 23:1530-1537
4. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710-1717
5. Goya T, Asamura H, Yoshimura H, et al. (2005) Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 50:227-234
6. Ichinose Y, Yano T, Yokoyama H, et al. (1994) Postrecurrent survival of patients with non-small-cell lung cancer undergoing a complete resection. J Thorac Cardiovasc Surg 108:158-161
7. Williams BA, Sugimura H, Endo C, et al. (2006) Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients. Ann Thorac Surg 81:1021-1027
8. Sugimura H, Nichols FC, Yang P, et al. (2007) Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg 83: 409-417; discussion 417-418
9. Mehta MP, Tsao MN, Whelan TJ, et al. (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63:37-46
10. Burt M, Wronski M, Arbit E, et al. (1992) Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center thoracic surgical staff. J Thorac Cardiovasc Surg 103: 399-410; discussion 410-411
11. Kim JE, Lee DH, Choi Y, et al. (2009) Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis. Lung Cancer 65:351-354
12. Lan KK, Rosenberger WF, Lachin JM (1995) Sequential monitoring of survival data with the Wilcoxon statistic. Biometrics 51:1175-1183
13. Nakamura H, Ando K, Shinmyo T, et al. (2011) Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis. Ann Thorac Cardiovasc Surg 17:469-480
14. Batevik R, Grong K, Segadal L, et al. (2005) The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years. Lung Cancer 47:173-181
15. Patchell RA (2003) The management of brain metastases. Cancer Treat Rev 29:533-540
16. Bradley KA, Mehta MP (2004) Management of brain metastases. Semin Oncol 31:693-701
17. Shiau CY, Sneed PK, Shu HK, et al. (1997) Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37:375-383
18. Flickinger JC, Kondziolka D, Lunsford LD, et al. (1994) A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797-802
19. Engenhart R, Kimmig BN, Hover KH, et al. (1993) Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer (Phila) 71:1353-1361
20. Adler JR, Cox RS, Kaplan I, et al. (1992) Stereotactic radiosurgical treatment of brain metastases. J Neurosurg 76:444-449
21. Mehta MP, Rozental JM, Levin AB, et al. (1992) Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 24:619-625
22. Sneed PK, Suh JH, Goetsch SJ, et al. (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519-526
23. Aoyama H, Shirato H, Tago M, et al. (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483-2491
24. Serizawa T, Saeki N, Higuchi Y, et al. (2005) Gamma knife surgery for brain metastases: indications for and limitations of a local treatment protocol. Acta Neurochir (Wien) 147: 721-726; discussion 726
25. Kihlstrom L, Karlsson B, Lindquist C (1993) Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience. Stereotact Funct Neurosurg 61(suppl 1):45-50
26. Borgelt B, Gelber R, Kramer S, et al. (1980) The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1-9
27. Asai A, Matsutani M, Kohno T, et al. (1989) Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer (Phila) 63:1962-1974
28. DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796
29. Kelly K, Bunn PA Jr (1998) Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer? Lung Cancer 20:85-91
30. Rubins J, Unger M, Colice GL, et al. (2007) Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest 132:355S-367S
31. Alberts WM (2007) Follow up and surveillance of the patient with lung cancer: what do you do after surgery? Respirology 12:16-21
32. Cotto C, Berille J, Souquet PJ, et al. (1996) A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer. Eur J Cancer 32A:69-71
33. Furuse K, Kamimori T, Kawahara M, et al. (1997) A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis. Br J Cancer 75:614-618